Chemotherapy for small intestine cancer

Last medical review:

Chemotherapy uses drugs that are cytotoxic to destroy cancer cells. Cytotoxic means the drugs are poisonous to all cells in your body – so these drugs destroy cancer cells, but they can also harm healthy cells. With most types of chemotherapy, the drugs travel through the blood to reach and destroy cancer cells all over the body, including cells that may have broken away from the primary tumour. This is described as systemic therapy.

Chemotherapy is sometimes used to treat small intestine adenocarcinoma, but the primary treatment is surgery. If you have chemotherapy, your healthcare team will use what they know about the cancer and about your health to plan the drugs, doses and schedules.

Chemotherapy may be the only treatment you have or it may be used along with other cancer treatments. You may have chemotherapy to:

  • destroy cancer cells left behind after surgery to reduce the risk that the cancer will come back (called adjuvant chemotherapy)

  • shrink an unresectable tumour so it can be removed with surgery (sometimes called conversion chemotherapy)
  • relieve pain or control the symptoms of metastatic small intestine adenocarcinoma (called palliative chemotherapy)

When chemotherapy is given before surgery, it may be combined with radiation (called chemoradiation).

Chemotherapy drugs used for small intestine adenocarcinoma

The most common chemotherapy drugs used for small intestine adenocarcinoma are fluorouracil (5-fluorouracil or 5-FU), oxaliplatin and irinotecan.

Common chemotherapy drugs and chemotherapy drug combinations used for small intestine adenocarcinoma cancer include:

  • FOLFOX – leucovorin (folinic acid), 5-FU and oxaliplatin
  • CAPOX – capecitabine (Xeloda) and oxaliplatin
  • FOLFIRI – leucovorin, fluorouracil and irinotecan
  • 5-FU or capecitabine
  • FOLFOXIRI – 5-FU, leucovorin, oxaliplatin and irinotecan

All chemotherapy drugs used for small intestine adenocarcinoma are given intravenously (through an IV) except for capecitabine, which is given as a pill.

Side effects

Side effects of chemotherapy will depend mainly on the drug, the dose, how it's given and your overall health. Tell your healthcare team if you have side effects that you think are from chemotherapy. The sooner you tell them of any problems, the sooner they can suggest ways to help you deal with them.

Common possible side effects of chemotherapy drugs for small intestine adenocarcinoma include:

Find out more about chemotherapy

Find out more about chemotherapy and side effects of chemotherapy. To make decisions that are right for you, ask your healthcare team questions about chemotherapy.

Details on specific drugs change quite regularly. Find out more about sources of drug information and where to get details on specific drugs.

Expert review and references

  • Shahid Ahmed , MD, FRCPC, PhD, FACP
  • Aparicio T, Zaanan A, Svrcek M, Laurent-Puig P, Carrere N, Manfredi S, Locher C, Afchain P . Small bowel adenocarcinoma: epidemiology, risk factors, diagnosis and treatment . Digestive and Liver Disease . 2014 .
  • Arber N, Moshkowitz M . Small intestinal cancers. Jankowiski J, Hawk E (eds.). Handbook of Gastrointestinal Cancer. Wiley-Blackwell; 2013: 4: 67-85.
  • Khan K, Peckitt C, Sclafani F, Watkins D, Rao S, Starling N, Jain V, et al . Prognostic factors and treatment outcomes in patients with Small Bowel Adenocarcinoma (SBA): The Royal Marsden Hospital (RMH) experience. BMC Cancer. 2015: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4305243/.
  • Kopacova M, Rejchrt S, Bures J, Tacheci I . Small intestinal tumours. Gastroenterology Research and Practice. 2013: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3855980/pdf/GRP2013-702536.pdf.
  • Raghav K, Katz MHG, Overman MJ . Cancers of the small bowel. Raghavan D, Blanke CD, Honson DH, et al (eds.). Textbook of Uncommon Cancer. 4th ed. Wiley Blackwell; 2012: 31: 441-464.
  • Accord Healthcare Inc.. Product Monograph: Capecitabine. 2021: https://pdf.hres.ca/dpd_pm/00063919.PDF.
  • Pfizer Canada ULC. Product Monograph: Oxaliplatin. 2020: https://pdf.hres.ca/dpd_pm/00057007.PDF.
  • Sandoz Canada Inc.. Product Monograph: Fluorouracil. 2012: https://pdf.hres.ca/dpd_pm/00016156.PDF.
  • Somasundar P. Medscape Reference: Malignant Neoplasms of the Small Intestine Treatment and Management. 2019: https://www.medscape.com/.
  • American Society of Clinical Oncology (ASCO) . Cancer.net: Small Bowel Cancer Types of Treatment . 2021 : https://www.cancer.net/.
  • PDQ Adult Treatment Editorial Board. Small Intestine Cancer Treatment (PDQ®) – Health Professional Version . Bethesda, MD: National Cancer Institute; 2022: https://www.cancer.gov/.
  • PDQ Adult Treatment Editorial Board. Small Intestine Cancer Treatment (PDQ®) – Patient Version . Bethesda, MD: National Cancer Institute; 2021: https://www.cancer.gov/.
  • American Cancer Society . Treating Small Intestine Cancer (Adenocarcinoma) . 2018 : https://www.cancer.org/.
  • Pfizer Canada. Product Monograph: Lederle Leucovorin. https://pdf.hres.ca/dpd_pm/00047740.PDF.
  • Teva Canada Limited. Product Monograph: Irinotecan . 2020: https://pdf.hres.ca/dpd_pm/00058570.PDF.

Medical disclaimer

The information that the Canadian Cancer Society provides does not replace your relationship with your doctor. The information is for your general use, so be sure to talk to a qualified healthcare professional before making medical decisions or if you have questions about your health.

We do our best to make sure that the information we provide is accurate and reliable but cannot guarantee that it is error-free or complete.

The Canadian Cancer Society is not responsible for the quality of the information or services provided by other organizations and mentioned on cancer.ca, nor do we endorse any service, product, treatment or therapy.


1-888-939-3333 | cancer.ca | © 2024 Canadian Cancer Society